prof. dr. J.L. (Hans) Hillege

Cardiology

E-mail:
h.hillege umcg.nl

Research

Publications
  1. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study

    Markousis-Mavrogenis, G., Tromp, J., Ouwerkerk, W., Devalaraja, M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G. S., van der Harst, P., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., Zannad, F., Zwinderman, A. H., Hillege, H. L., van Veldhuisen, D. J., Kakkar, R., Voors, A. A. & van der Meer, P., Aug-2019, In : European Journal of Heart Failure. 21, 8, p. 965-973 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study

    ASIAN-HF Investigators, Santema, B. T., Ouwerkerk, W., Tromp, J., Sama, I. E., Ravera, A., Regitz-Zagrosek, V., Hillege, H., Samani, N. J., Zannad, F., Dickstein, K., Lang, C. C., Cleland, J. G., Ter Maaten, J. M., Metra, M., Anker, S. D., van der Harst, P., Ng, L. L., van der Meer, P., van Veldhuisen, D. J., Meyer, S., Lam, C. S. P. & Voors, A. A., 5-Oct-2019, In : The Lancet. 394, 10205, p. 1254-1263 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF

    Suzuki, T., Yazaki, Y., Voors, A. A., Jones, D. J. L., Chan, D. C. S., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M. & Ng, L. L., Jul-2019, In : European Journal of Heart Failure. 21, 7, p. 877-886 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation

    Mordi, I. R., Santema, B. T., Kloosterman, M., Choy, A-M., Rienstra, M., van Gelder, I., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Metra, M., Ng, L. L., Ouwerkerk, W., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Voors, A. A. & Lang, C. C., Jul-2019, In : Clinical Research in Cardiology. 108, 7, p. 797-805 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (453) »

Activities
  1. Netherlands Society of Cardiology/Nederlandse Vereniging voor Cardiologie (NVVC) (External organisation)

    Hans Hillege (Member)
    1-Jan-2018

    Activity: MembershipMembership of networkProfessional

  2. Quantitative Benefit-Risk Assessment

    Hans Hillege (Speaker), Douwe Postmus (Speaker)
    26-Aug-2018

    Activity: Talk or presentationProfessional

View all (3) »

View graph of relations

ID: 85102